|
|
| Ashrafi, Kaveh |
| Bernstein, Harold S. |
| Black, Brian L |
| Blanc, Paul D |
| Botvinick, Elias H |
| Boushey, Homer A |
| Broaddus, V Courtney |
| Brodsky, Frances M |
| Brown, James K |
| Bruneau, Benoit G |
| Caughey, George H |
| Chapman, Harold A |
| Charo, Israel F |
| Chatterjee, Kanu |
| Chuang, Pao-Tien |
| Clyman, Ronald I |
| Conklin, Bruce R |
| Conte, Michael S |
| Coughlin, Shaun R |
| Derynck, Rik M |
| Dobbs, Leland G |
| Eisner, Mark D |
| Engel, Joanne N |
| Erle, David J |
| Fahy, John Vincent |
| Farese, Robert V |
| Fielding, Christopher J |
| Fineman, Jeffrey R |
| Gardner, David G |
| Gartner, Zev Jordan |
| Glantz, Stanton A |
| Gold, Warren M |
| Gropper, Michael |
| Grossman, William |
| Hawgood, Samuel |
| Hill, Arthur C |
| Hoffman, Julien I |
| Ingraham, Holly A |
| Jan, Lily Y |
| Julius, David J |
| Kan, Yuet W |
| Kane, John P |
| Karliner, Joel S |
| Kornberg, Thomas B |
| Kurtz, Theodore W |
| Kwok, Pui-Yan |
| Lazarus, Stephen C |
| Lee, Randall J |
| Lim, Wendell A |
| Mahley, Robert W |
| Malloy, Mary J. |
| Mann, Michael J |
| Martin, Gail R |
| Matthay, Michael A |
| Mcdonald, Donald M |
| Mikawa, Takashi |
| Minor, Daniel L |
| Mostov, Keith E |
| Nadel, Jay A |
| Olgin, Jeffrey E |
| Pearce, David |
| Pittet, Jean-Francois |
| Redberg, Rita F |
| Reiter, Jeremy F. |
| Rosen, Steven D |
| Rowitch, David H |
| Scheinman, Melvin M |
| Schiller, Nelson B |
| Shaw, Robin M. |
| Sheppard, Dean |
| Shokat, Kevan M |
| Simpson, Paul C |
| Springer, Matthew L |
| Srivastava, Deepak |
| Stainier, Didier Y. R. |
| Teitel, David F |
| Von Zastrow, Mark E |
| Wang, Rong |
| Weiner, Orion D |
| Weiss, Arthur |
| Weiss, Ethan J |
| Werb, Zena |
| Woodruff, Prescott G |
| Xu, Allison Wanting |
| Young, William L |
|
CVRI Scientists
Michael J Mann, M.D.
Research Interests:
1. Molecular/cellular biology and molecular genetics of atherosclerosis and heart failure.
2. Development of hybrid surgical and molecular/cellular therapies for heart disease.
3. Stem and progenitor cell transplantation for cardiovascular regeneration.
4. Cardiovascular tissue engineering.
5. Reduction to clinical practice of current methods in genetic, molecular and cellular disease intervention.
6. Novel targeted molecular therapies for lung cancer.
7. Molecular profiling of cancers for personalized medicine.
8. Development of novel methods of in vivo/ex vivo gene therapy and gene transfer.
9. Novel approaches to therapeutic neovascularization for coronary and peripheral ischemic disease.
10. Cardiovascular cell cycle biology.
11. Myocardial gene therapy.
Summary:
Dr. Mann's research focuses on the molecular and cellular biology of heart disease with an emphasis on practical ways to develop new treatments for heart failure. These involve potential gene and molecular therapies, combinations of molecular and cell-based treatments with surgical reconstruction, and evaluation of novel materials for the development of bioartificial replacements of lost or damaged heart tissue.
|
|
|
